Alivus Life Sciences Ltd.

Alivus Life Sciences has informed that pursuant to Regulation 30 and Para A of Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, details of the meetings with Investor/Analyst which will be held on June 12, 2025 and attended by the representatives of the Company is enclosed.

The above information is a part of company’s filings submitted to BSE.